Alone, together: On the benefits of Bayesian borrowing in a meta-analytic setting

Pharm Stat. 2023 Sep-Oct;22(5):903-920. doi: 10.1002/pst.2318. Epub 2023 Jun 15.

Abstract

It is common practice to use hierarchical Bayesian model for the informing of a pediatric randomized controlled trial (RCT) by adult data, using a prespecified borrowing fraction parameter (BFP). This implicitly assumes that the BFP is intuitive and corresponds to the degree of similarity between the populations. Generalizing this model to any K 1 historical studies, naturally leads to empirical Bayes meta-analysis. In this paper we calculate the Bayesian BFPs and study the factors that drive them. We prove that simultaneous mean squared error reduction relative to an uninformed model is always achievable through application of this model. Power and sample size calculations for a future RCT, designed to be informed by multiple external RCTs, are also provided. Potential applications include inference on treatment efficacy from independent trials involving either heterogeneous patient populations or different therapies from a common class.

Keywords: Bayesian borrowing; clinical trial design; empirical Bayes.

Publication types

  • Meta-Analysis

MeSH terms

  • Adult
  • Bayes Theorem
  • Child
  • Computer Simulation
  • Humans
  • Models, Statistical*
  • Randomized Controlled Trials as Topic
  • Research Design*
  • Sample Size

Grants and funding